Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?

Raymond N. DuBois

    Research output: Contribution to journal › Editorial › peer-review

    7 Scopus citations

    Fingerprint

    Dive into the research topics of 'Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?'. Together they form a unique fingerprint.